[Septrin in the treatment of chronic pyelonephritis and certain other bacterial infections. Immediate effect of treatment after short-term administration of the drug].
D000208:Acute Disease; D000328:Adult; D000368:Aged; D001991:Bronchitis / Q000188:drug therapy; D002908:Chronic Disease; D004755:Enterobacteriaceae / Q000302:isolation & purification; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D004926:Escherichia coli / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D007709:Klebsiella / Q000302:isolation & purification; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011511:Proteus / Q000302:isolation & purification; D011512:Proteus Infections / Q000188:drug therapy; D011549:Pseudomonas / Q000302:isolation & purification; D011552:Pseudomonas Infections / Q000188:drug therapy; D011704:Pyelonephritis / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use*; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000302:isolation & purification; D013290:Streptococcal Infections / Q000188:drug therapy; D013291:Streptococcus / Q000302:isolation & purification; D013420:Sulfamethoxazole / Q000627:therapeutic use*
D005493:Folic Acid Antagonists; D011743:Pyrimidines; D013420:Sulfamethoxazole
Septrin w leczeniu przewlekłego odmiedniczkowego zapalenia nerek oraz niektórych innych zakzzeń bakteryjnych. Bezpośredni wynik leczenia po krótkotrwałym podawaniu leku.